HUNTINGTON NATIONAL BANK - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$43,000
-2.3%
1,0250.0%0.00%0.0%
Q4 2019$44,000
+2100.0%
1,025
+925.0%
0.00%
Q4 2018$2,000100
+270.4%
0.00%
Q3 2016$0270.0%0.00%
Q2 2016$0
-100.0%
27
-64.5%
0.00%
Q1 2016$2,000
-33.3%
76
+4.1%
0.00%
Q4 2015$3,0000.0%73
-6.4%
0.00%
Q3 2015$3,0000.0%78
+9.9%
0.00%
Q2 2015$3,000
+50.0%
71
-6.6%
0.00%
Q1 2015$2,000
-33.3%
76
-29.0%
0.00%
Q4 2014$3,0001070.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders